Suppr超能文献

梯牧草(早熟禾)花粉主要过敏原的cDNA克隆;重组Phl pV过敏原的特性分析

cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen.

作者信息

Vrtala S, Sperr W R, Reimitzer I, van Ree R, Laffer S, Müller W D, Valent P, Lechner K, Rumpold H, Kraft D

机构信息

Institute of General and Experimental Pathology, University of Vienna, Austria.

出版信息

J Immunol. 1993 Nov 1;151(9):4773-81.

PMID:7691956
Abstract

We isolated a cDNA encoding a major grass pollen allergen from a timothy grass (Phleum pratense) pollen expression cDNA library using allergic patients' IgE. The complete cDNA encoded an allergen that binds IgE from about 80% of grass pollen-allergic patients. Significant sequence homology was found to other major grass pollen allergens from Kentucky bluegrass (Poa pratense) as well as from rye grass (Lolium perenne) which originally were believed to form different identities. Using different monoclonal and polyclonal antibodies raised against group V allergens we identified the recombinant protein as a group V allergen from timothy grass, Phl p V. In IgE-binding studies it is demonstrated that the rPhl p V allergen can be used to block binding of patients' IgE to natural group V isoallergens on two-dimensional immunoblots. IgE inhibition experiments show that up to 60% of grass pollenspecific IgE can be preadsorbed with the rPhl p V allergen from patients sera. The purified rPhl p V induced specific histamine release of blood basophils from grass pollen-allergic patients. This emphasizes the usefulness of the rPhl p V for diagnostic and therapeutic purposes and corroborates the view that specific diagnosis and therapy of type l allergy could be performed with a limited panel of relevant recombinant allergens.

摘要

我们利用过敏患者的免疫球蛋白E(IgE),从梯牧草(Phleum pratense)花粉表达cDNA文库中分离出一个编码主要草花粉过敏原的cDNA。该完整的cDNA编码一种能与约80%的草花粉过敏患者的IgE结合的过敏原。研究发现,它与来自草地早熟禾(Poa pratense)以及黑麦草(Lolium perenne)的其他主要草花粉过敏原具有显著的序列同源性,而这些过敏原最初被认为具有不同的特性。我们使用针对V组过敏原产生的不同单克隆抗体和多克隆抗体,将该重组蛋白鉴定为梯牧草的V组过敏原,即Phl p V。在IgE结合研究中表明,重组Phl p V过敏原可用于在二维免疫印迹中阻断患者IgE与天然V组同种变应原的结合。IgE抑制实验表明,患者血清中的重组Phl p V过敏原可预吸附高达60%的草花粉特异性IgE。纯化后的重组Phl p V可诱导草花粉过敏患者的血液嗜碱性粒细胞释放特异性组胺。这强调了重组Phl p V在诊断和治疗方面的实用性,并证实了这样一种观点,即可以用一组有限的相关重组过敏原进行I型过敏的特异性诊断和治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验